Two Years of Genomic Surveillance in Belgium during the SARS-CoV-2 Pandemic to Attain Country-Wide Coverage and Monitor the Introduction and Spread of Emerging Variants.
peer reviewed ; An adequate SARS-CoV-2 genomic surveillance strategy has proven to be essential for countries to obtain a thorough understanding of the variants and lineages being imported and successfully established within their borders. During 2020, genomic surveillance in Belgium was not structurally implemented but performed by individual research laboratories that had to acquire the necessary funds themselves to perform this important task. At the start of 2021, a nationwide genomic surveillance consortium was established in Belgium to markedly increase the country's genomic sequencing e... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | journal article |
Erscheinungsdatum: | 2022 |
Verlag/Hrsg.: |
NLM (Medline)
|
Schlagwörter: | Belgium / COVID-19 / SARS-CoV-2 / genomic surveillance / next-generation sequencing / variants of concern / Humans / Belgium/epidemiology / Genome / Viral / Genomics / SARS-CoV-2/genetics / High-Throughput Nucleotide Sequencing / COVID-19/epidemiology / Pandemics / Infectious Diseases / Virology / Life sciences / Genetics & genetic processes / Sciences du vivant / Génétique & processus génétiques |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28543562 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://orbi.uliege.be/handle/2268/299183 |